Shriram Finance expects cost of funds to fall 1% following capital infusion from MUFG

Mumbai, April 24 -- Shriram Finance Ltd expects its cost of funds to decline by around 1% over the next 18 months as the non-banking financial company (NBFC) looks to restructure its debt following a ... Read More

Paige Shiver says ex-Michigan coach Sherrone Moore was 'controlling'; lost his baby during 'ugly' affair: Report

New Delhi, April 24 -- Former University of Michigan football coach Sherrone Moore's ex-assistant Paige Shiver revealed Friday that she lost Moore's baby due to a medical emergency. Shiver told ABC N... Read More

Worried that your US Social Security benefits won't beat inflation? Here's what you need to know about COLA

New Delhi, April 24 -- US Social Security benefits serve as the financial backbone for nearly 57 million retirees who rely on these payouts. However, over time, these benefits start becoming inadequat... Read More

The new 'hybrid threat': Spies, arson and digital grooming

India, April 24 -- LUCKNOW A string of recent arrests across UP and the National Capital Region (NCR) has revealed an expanding and increasingly complex threat network combining espionage, online radi... Read More

Saudi health executive joins Cannes Lions 2026 jury

Jakarta, April 24 -- The Cannes Lions International Festival of Creativity has named Muhannad Abdullah Kadi to its 2026 jury for the Health and Wellness category, marking a first for a Saudi healthcar... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending... Read More

Singapore Clinical Trial: A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozanti... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More

Singapore Clinical Trial: Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled 'Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)'. The following are the oth... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 24 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More

• ««
• «
• 1005
• 1006
• 1007
• 1008
• 1009
• 1010
• 1011
• 1012
• 1013
• 1014
• »
• »»